Pfizer Inc (PFE) Down 2.15%, Crosses 50, 100 and 200 Day Moving Averages; in a Downtrend Over Past 14 Days

Pfizer Inc 4 Hour Price Update

Updated September 04, 2020 04:35 PM GMT (12:35 PM EST)

PFE’s price is down $-0.27 (-0.73%) over the past four hours of trading. To help put that in perspective, note that Pfizer Inc’s peers in the in the Pharmaceutical Products industry are down -2% on average during this time, while its peers in the broader Healthcare sector are down by an average of -2.07%.

Pfizer Inc Daily Price Recap

Pfizer Inc entered today at $36.4, down 2.15% ($0.8) from the day prior. As for how volume fared, yesterday’s volume was up 23.7% from the previous day (Wednesday), and up 37.06% from Thursday of the week before. Let’s take a look at the daily price chart of Pfizer Inc.

PFE

Pfizer Inc Technical Analysis

Moving average crossovers are always interesting, so let’s start there: Pfizer Inc crossed below its 50, 100 and 200 day moving averages yesterday. Trend traders will want to observe that the strongest trend appears on the 14 day horizon; over that time period, price has been moving down. For additional context, note that price has gone down 7 out of the past 10 days.

Overheard Around the Web

Here’s what one trader on StockTwits recently had to say in regards to PFE:

    $MRNA $PFE $BNTX

    Russian vaccine is a joke. Lancet publication is about early stage phases nothing about a late stage phase 3 trial as Russia skipped it.

    Moderna, PFE/BioNTech are far ahead with phase 3 trial in progress with potential FDA Emergency Use Authorization coming in October.

    US, Europe and parts of Asia with strict regulations will never use the vaccines from Russia or China.

    Buy more at a discount now and hold. Big tech investors will rotate to Covid stocks where the action is in Q3 and Q4.

    Analysts are predicting our stocks will surpass all time high:
    BNTX > $100
    PFE > $40
    MRNA > $95

    JohnnyTheBull